Henry Skinner, Satish Jindal,Patrick Carroll, Paulette Dillon, Mark Lotz, Jack Wyszomierski, James Simpkins, Neil Hocking, Steven Deitcher | GenomeWeb

Henry Skinner has been promoted to CEO from chief business officer of NeoGenesis Pharmaceuticals. He will also serve on the company’s board of directors. Skinner replaces Satish Jindal, who stays on as NeoGenesis’ CSO and chairman of its board. Before joining NeoGenesis last fall, Skinner was senior director for technology acquisitions and operations at Pfizer, working for its Pharmacia unit.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.